Register now for this upcoming Endo-ERN webinar.
Genetic obesity is associated with difficulties in the regulation of appetite and satiety, often resulting in behavioural difficulties around food and consequent severe obesity. GLP-1 agonists affect appetite and satiety and may benefit these patients. In this webinar, the role of GLP-1 agonists in genetic obesity conditions such as Bardet Biedl, Alström and Prader-Willi syndromes will be discussed, and the impact of behaviour on the patient and carers will be explored.
Chaired by MTG5 Chairs Charlotte Höybye, Adult chair, Karolinska University Hospital, Sweden & Susan O’Connell, Paediatric chair, Children’s Health Ireland, Ireland
Speakers:
– Julia von Schnurbein, Ulm University Medical Center, Germany
– Tony Goldstone, Imperial College Healthcare NHS Trust
– Bernd Rosenbichler, Alström Syndrom e.V.
You will have the opportunity to ask questions directly at the end of the webinar.
Unable to attend live? Register and you will receive a recording of the webinar afterwards.
Webinar summary
| Webinar | Management of genetic obesity and food seeking behaviour e.d. in BBS/ALSTRÖM/PRADER WILLI syndromes / use of GLP-1 agonists in these conditions |
| Date | December 6th, 2024 |
| Time | 14:00 – 15:00 hr |
| Speakers | dr. Julia von SchnurbeinDr Tony Goldstone Bernd Rosenbichler |
| Registration | Register for webinar |
| MTG | |
| Add this event to your calendar |
